
Sign up to save your podcasts
Or


On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.

303 Listeners

51 Listeners

28,209 Listeners

113,219 Listeners

148 Listeners

882 Listeners

51 Listeners

5,481 Listeners

6,103 Listeners

124 Listeners

2,183 Listeners

81 Listeners